In October 2004, the UK Medicines and Healthcare products Regulatory Agency (MHRA) suspended Chiron’s manufacturer’s license for the Fluvirin influenza vaccine at the Liverpool production site. Following the
The company’s consumer medicines businesses in Japan, China, Latin America Europe, Middle East and Africa are not included in this divestiture. Bristol-Myers Squibb’s primary consumer medicine brands in
Nasonex remains the only once-daily prescription nasal inhaled steroid approved to help prevent most seasonal nasal allergy symptoms, including nasal congestion, in adults and children 12 years of
The focus of the cooperative R&D agreement (CRADA) is heat shock protein 90 (Hsp90), a target of considerable current scientific interest because of its potential pathophysiological role in
Rambazole is a novel retinoic acid metabolism-blocking agent (RAMBA). A review of initial phase IIa trial data from ten patients with moderate to severe psoriasis demonstrated a reduction
In a recent exploratory phase IIa study, Miraxion (formerly referred to as LAX-101c) was used as monotherapy in 77 patients with a new episode of depression in a
The phase III trial is designed to determine the ability of Flurizan (MPC-7869) to alter the course of cognitive decline and behavioral change in patients with Alzheimer’s disease.
The Bilive production license has now been issued by the SFDA and sales of the vaccine will commence in China shortly. This is the first combined inactivated hepatitis
The study shows that when US and European patients receive health information on how to manage their condition, nearly two thirds make proactive changes in their behavior based
Safinamide was also found to be well tolerated and did not exhibit any clinically relevant side-effects in patients with restless legs syndrome (RLS), a neurological disorder characterized by
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.